Pfizer's high initial dividend yield, solid ratings, and promising pipeline make it a potentially undervalued investment. See ...

Pfizer's stock appears undervalued with a high dividend yield of 6.8%, making it a potential long-term investment despite low growth expectations. The company reported strong Q3 results with 31.2% YoY ...

Investors looking for a way to pump up their passive income streams want to turn their attention toward the pharmaceutical ...

Maintaining dividend aristocrat status isn’t easy, as it requires companies to pay out dividends consistently (and raise them ...

The market is still punishing Pfizer for its past and not considering its bright future. Johnson & Johnson is a slow, steady ...

Moderna is a good investment for the vaccine market, while Pfizer is a diversified firm trading at a discount. PFE stock is a ...

Collecting an above-average dividend payment can sometimes come with risks. High-yielding stocks can be due for cuts to their payouts if a company's underlying financials aren't strong enough to ...

Pfizer Inc. (NYSE:PFE – Get Free Report) was the target of some unusual options trading activity on Friday. Investors ...

This represents a $1.68 annualized dividend and a dividend yield of 6.55%. The ex-dividend date of this dividend is Friday, ...

The fourth-quarter 2024 cash dividend will be the 344th consecutive quarterly dividend paid by Pfizer. NEW YORK, October 08, 2024--Pfizer Inc. (NYSE: PFE) will present data across its infectious ...

(GLOBE NEWSWIRE) -- (TSX: REAL) (“Real Matters” or the “Company”), a leading network management services platform for the ...

Dividend stocks provide investors with reliable passive income. These four health care picks look like outstanding ideas now.